Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on April 30, 2025

Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
FINDLAY, Ohio, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding Nerve Pain and the Promise of Arialief Millions of people worldwide suffer silently from nerve pain — a condition that slowly steals mobility, independence, and quality of life. …

WellSpan Surgery and Rehabilitation Hospital reaccredited with top Magnet designation
York, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- WellSpan Surgery and Rehabilitation Hospital in York has been reaccredited as a Magnet hospital, the highest honor for nursing, awarded by the American Nurses Credentialing Center (ANCC). As part of the …

Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapies
Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and supported by Pathway to Cures—to accelerate the …

X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement builds on an existing relationship …

ScribeAmerica to Showcase Provider Enablement Solutions at UCA’s 2025 Urgent Care Convention
FORT LAUDERDALE, FLORIDA, April 30, 2025 (GLOBE NEWSWIRE) -- ScribeAmerica is proud to announce its participation in the 2025 Urgent Care Convention, taking place May 2-6 in Dallas, TX. The company will exhibit in the Solutions. Expo at booth #1019, where …

BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton …

Corporate Update
Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to the OTCQB Exchange. The Company …

HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the catalyst for global healthcare innovation, returns to Las Vegas on October 19–22, 2025, with a bold new agenda designed to redefine the future of healthcare. Led by new, immersive marketplaces …

Best Male Enhancement Pills – Top Natural Male Enhancement Supplements & Gummies: Erectin Under Review By Leading Edge Health
Limassol, Cyprus, April 30, 2025 (GLOBE NEWSWIRE) -- Every man wants to perform like a stud in the bedroom and beyond. We’d like to wield powerful erections, climax with massive force, last all night long, and leave our partners begging for more. The best …

Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
MELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in innovative technology and wellness solutions, is thrilled to announce that Michael Lawson has assumed the roles of Chief Executive Officer and …

AAPA 2025 Salary Report: Rising Compensation Confirms PA Profession’s Vital Role in Healthcare System
Alexandria, Va., April 30, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) has released the findings of its 2025 AAPA Salary Report, shedding light on key trends shaping the physician associate/assistant (PA) profession. …

INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …

Helius Medical Technologies Announces Reverse Stock Split
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced …

Senti Bio to Present at the Citizens JMP Life Sciences Conference
Live video webcast presentation on Thursday, May 8th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with Relapsed/Refractory AML SOUTH SAN …

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of …

PathAI to Present at Digestive Disease Week
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6, 2025, in San …

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …

PharmAla Issues Q2 Financial Statements
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA …

Elligint Health Partners with CareCo to Transform Care Coordination and Utilization Management with Advanced AI Workflow Tools and Integrated AI-Powered VoIP System
KINGSTON, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Elligint Health, parent company of VirtualHealth, is excited to announce a strategic partnership with CareCo to deliver next-generation healthcare solutions. This groundbreaking collaboration will integrate …

Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a lot of illnesses, and contrary to what people believe, it does not enter the body out of thin air. A person becomes stressed when there is a deficiency of Magnesium in the …